About this trial
There is a lack of prospective observational studies of shockwave balloons in the treatment of moderate-to-severe calcification of the femoral popliteal artery at the international level. Therefore, in this study, we wish to set up a real-world study of shockwave balloon in the treatment of moderate-to-severe calcification to investigate the real-world efficacy of shockwave balloon in the treatment of moderate-to-severe calcified lesions.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with stroke, cerebral hemorrhage, gastrointestinal hemorrhage, or cardiac infarction within 3 months prior to enrollment (2) Patients with known allergy to heparin, aspirin, other antiplatelet drugs, contrast agents, etc.
Trial design
Treatments tested in this trial
- Shockwave balloons
Treatment groups
Sponsors and collaborators
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Lead sponsor
Shanghai Zhongshan Hospital
Collaborator
Huashan Hospital
Collaborator
Xuanwu Hospital, Beijing
Collaborator
The General Hospital of Southern Theater Command
Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator
RenJi Hospital
Collaborator
Chengdu University of Traditional Chinese Medicine
Collaborator